var data={"title":"Clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/contributors\" class=\"contributor contributor_credentials\">Marcio Nucci, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/contributors\" class=\"contributor contributor_credentials\">Arnaldo L Colombo, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/contributors\" class=\"contributor contributor_credentials\">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/contributors\" class=\"contributor contributor_credentials\">Jennifer Mitty, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 15, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Paracoccidioidomycosis is a systemic endemic mycotic disease caused by thermally dimorphic fungi of the genus <em>Paracoccidioides</em>. Two species are recognized to cause paracoccidioidomycosis: <em>Paracoccidioides brasiliensis</em> and <em>Paracoccidioides lutzii</em>. The fungus has a geographic distribution limited to Central and South America, where paracoccidioidomycosis is the most frequent systemic endemic mycosis.</p><p>The clinical manifestations and diagnosis of <span class=\"nowrap\">acute/subacute</span> (juvenile) paracoccidioidomycosis will be reviewed here. The clinical manifestations and diagnosis of chronic paracoccidioidomycosis, as well as the mycology, epidemiology, and treatment of paracoccidioidomycosis are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-paracoccidioidomycosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of chronic paracoccidioidomycosis&quot;</a> and <a href=\"topic.htm?path=mycology-and-epidemiology-of-paracoccidioidomycosis\" class=\"medical medical_review\">&quot;Mycology and epidemiology of paracoccidioidomycosis&quot;</a> and <a href=\"topic.htm?path=treatment-of-paracoccidioidomycosis\" class=\"medical medical_review\">&quot;Treatment of paracoccidioidomycosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Only a minority of patients (&lt;5 percent) eventually develop clinically manifested disease. Following inhalation, <em>Paracoccidioides </em>typically causes asymptomatic pulmonary infection that may be detected by a positive paracoccidioidin intradermal test. If the infection is not contained by the host, the disease may evolve into one of two patterns: the <span class=\"nowrap\">acute/subacute</span> form, which can appear as early as 45 days after an exposure [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/1\" class=\"abstract_t\">1</a>]; or the chronic form, which represents reactivation of the primary infection and is most common [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-paracoccidioidomycosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of chronic paracoccidioidomycosis&quot;</a>.)</p><p><span class=\"nowrap\">Acute/subacute</span> paracoccidioidomycosis (also known as juvenile paracoccidioidomycosis) is almost always observed in children, adolescents, and adults under 30 years of age, and represents fewer than 10 percent of cases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/3,4\" class=\"abstract_t\">3,4</a>]. In children, it affects girls and boys in equal numbers. This is in contrast to the chronic form, which is much more frequent in adult men. (See <a href=\"topic.htm?path=mycology-and-epidemiology-of-paracoccidioidomycosis#H3\" class=\"medical medical_review\">&quot;Mycology and epidemiology of paracoccidioidomycosis&quot;, section on 'Epidemiology'</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Signs and symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dissemination of infection to the reticuloendothelial system results in lymphadenopathy, hepatosplenomegaly, <span class=\"nowrap\">and/or</span> bone marrow dysfunction (eg, aplastic anemia) (<a href=\"image.htm?imageKey=ID%2F65466\" class=\"graphic graphic_table graphicRef65466 \">table 1</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/5\" class=\"abstract_t\">5</a>]. Constitutional signs such as fever and weight loss occur frequently. Less common features include bone and skin involvement (<a href=\"image.htm?imageKey=ID%2F54429\" class=\"graphic graphic_picture graphicRef54429 \">picture 1</a>). In contrast to the chronic form, lung involvement is very unusual with the <span class=\"nowrap\">acute/subacute</span> form.</p><p>Superficial lymph node involvement is most common in the cervical, axillary, and inguinal regions, and draining fistulae may develop (<a href=\"image.htm?imageKey=ID%2F54429\" class=\"graphic graphic_picture graphicRef54429 \">picture 1</a> and <a href=\"image.htm?imageKey=ID%2F52733\" class=\"graphic graphic_picture graphicRef52733 \">picture 2</a>). Enlarged abdominal lymph nodes often cause diffuse abdominal pain and occasionally compression of various structures such as the biliary tract (jaundice), and intestines (partial obstruction, malabsorption).</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Laboratory abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In a study of 63 children with paracoccidioidomycosis, the following laboratory abnormalities were observed [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/5\" class=\"abstract_t\">5</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anemia &ndash; 90 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypergammaglobulinemia &ndash; 89 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eosinophilia &ndash; 76 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypoalbuminemia &ndash; 73 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperbilirubinemia &ndash; 44 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mildly elevated transaminases &ndash; 20 percent</p><p/><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Clinical course</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical course progresses rapidly, and if left untreated, the patient's condition becomes seriously compromised within weeks to a few months [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/6\" class=\"abstract_t\">6</a>]. The course of <span class=\"nowrap\">acute/subacute</span> paracoccidioidomycosis is generally more severe than the chronic form [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/3,5,6\" class=\"abstract_t\">3,5,6</a>]. (See <a href=\"topic.htm?path=treatment-of-paracoccidioidomycosis#H27\" class=\"medical medical_review\">&quot;Treatment of paracoccidioidomycosis&quot;, section on 'Prognosis'</a>.)</p><p>Sequelae in patients with acute paracoccidioidomycosis are infrequent, and mostly represented by malabsorption related to fibrosis of mesenteric lymph nodes.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of <span class=\"nowrap\">acute/subacute</span> paracoccidioidomycosis includes lymphoma and systemic infections associated with generalized lymphadenopathy, hepatosplenomegaly, fever, weight loss and anemia. Infections that may have a similar clinical presentation include disseminated histoplasmosis, tuberculosis, syphilis, cat scratch disease, and a mononucleosis-like syndrome lasting more than 4 weeks (eg, Epstein-Barr virus, cytomegalovirus, <em>Toxoplasma gondii</em>). Primary HIV infection should also be considered in patients with risk factors.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">DIAGNOSTIC TESTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of paracoccidioidomycosis is based upon the microscopic visualization of fungal elements suggestive of <em>Paracoccidioides </em>spp <span class=\"nowrap\">and/or</span> by culturing this fungus from clinical specimens [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/4\" class=\"abstract_t\">4</a>]. Serologic testing can be useful both for diagnosis and for monitoring the response to therapy [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/7\" class=\"abstract_t\">7</a>]. The tests used to diagnose <span class=\"nowrap\">acute/subacute</span> paracoccidioidomycosis are identical to those used for chronic paracoccidioidomycosis, and are discussed in detail separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-paracoccidioidomycosis#H10\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of chronic paracoccidioidomycosis&quot;, section on 'Diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><span class=\"nowrap\">Acute/subacute</span> paracoccidioidomycosis should be considered in children or young adults (&lt;30 years old) with the following clinical presentation (or a combination of them):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fever</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Weight loss</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Localized or generalized superficial lymphadenopathy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatosplenomegaly</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abdominal masses (lymph nodes) with or without compressive manifestations</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Signs of bone marrow failure (especially anemia)</p><p/><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Approach to diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of paracoccidioidomycosis is sought in patients who present with suggestive epidemiological and clinical findings. A typical example would be a child or adolescent from a rural area who presents with fever, weight loss, and diffuse lymphadenopathy. The diagnosis of the <span class=\"nowrap\">acute/subacute</span> form of paracoccidioidomycosis is most often established by direct examination and culture of material obtained by aspiration of enlarged superficial lymph nodes, as well as by results of serologic tests.</p><p>The initial evaluation should include all of the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Imaging of affected areas to determine the extent of lymph node involvement (including the presence of compressive manifestations). All patients should be evaluated by abdominal ultrasound or abdominal computed tomography (CT). Chest CT is usually not performed and is important only if signs and symptoms suggest lung involvement (rare) or mediastinal lesion (eg, compression of superior vena cava). Gallium-67 scans may be of help in revealing bone lesions [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/8\" class=\"abstract_t\">8</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Direct examination and culture of specimens obtained by aspiration or biopsy of enlarged lymph nodes are routinely performed.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serologic testing (preferably by quantitative immunodiffusion). Antibody titers in the serum (by immunodiffusion) are usually high (&ge;1:32) in patients with acute paracoccidioidomycosis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-paracoccidioidomycosis#H14\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of chronic paracoccidioidomycosis&quot;, section on 'Serologic tests'</a>.)</p><p/><p>In addition, patients should be assessed for the presence and severity of bone marrow failure, and nutritional status. Additional tests may be indicated depending on the presence of clinical findings suggestive of involvement of other organs (eg, central nervous system, gastrointestinal tract, adrenal, bone, joints).</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">IMMUNOCOMPROMISED HOSTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Paracoccidioidomycosis in HIV-infected patients has some features in common with the <span class=\"nowrap\">acute/subacute</span> form of the disease, such as widespread involvement and rapid progression [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/9\" class=\"abstract_t\">9</a>]. In addition, patients with paracoccidioidomycosis and HIV may present with simultaneous lung involvement and generalized lymphadenopathy, making it difficult to differentiate between acute and chronic forms [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/10\" class=\"abstract_t\">10</a>]. Chronic paracoccidioidomycosis in immunocompromised hosts is discussed in a separate topic review. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-paracoccidioidomycosis#H20\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of chronic paracoccidioidomycosis&quot;, section on 'Immunocompromised hosts'</a>.) </p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Paracoccidioidomycosis is a systemic endemic mycotic disease caused by the thermally dimorphic fungi <em>Paracoccidioides brasiliensis </em>and <em>Paracoccidioides lutzii</em>, which have a geographic distribution limited to Central and South America. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Paracoccidioides</em> typically causes asymptomatic pulmonary infection. However, if the infection is not contained by the host, the disease may evolve into one of two patterns: the chronic form, which represents reactivation of the primary infection, and the <span class=\"nowrap\">acute/subacute</span> form. (See <a href=\"#H2\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><span class=\"nowrap\">Acute/subacute</span> paracoccidioidomycosis (also known as juvenile paracoccidioidomycosis) is almost always observed in children, adolescents, and adults under 30 years of age, and represents fewer than 10 percent of all cases of paracoccidioidomycosis. (See <a href=\"#H2\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In <span class=\"nowrap\">acute/subacute</span> paracoccidioidomycosis, dissemination of infection to the reticuloendothelial system results in lymphadenopathy, hepatosplenomegaly, and bone marrow dysfunction (eg, aplastic anemia). Constitutional signs such as fever and weight loss are common. (See <a href=\"#H3\" class=\"local\">'Signs and symptoms'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of paracoccidioidomycosis is based upon the microscopic visualization of fungal elements suggestive of P. brasiliensis <span class=\"nowrap\">and/or</span> by culturing this fungus from clinical specimens. Serologic testing can be useful both for diagnosis and for monitoring the response to therapy. (See <a href=\"#H7\" class=\"local\">'Diagnostic tests'</a> above and <a href=\"#H9\" class=\"local\">'Approach to diagnosis'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/1\" class=\"nounderline abstract_t\">Buccheri R, Khoury Z, Barata LC, Benard G. Incubation Period and Early Natural History Events of the Acute Form of Paracoccidioidomycosis: Lessons from Patients with a Single Paracoccidioides spp. Exposure. Mycopathologia 2016; 181:435.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/2\" class=\"nounderline abstract_t\">Travassos LR, Taborda CP, Colombo AL. Treatment options for paracoccidioidomycosis and new strategies investigated. Expert Rev Anti Infect Ther 2008; 6:251.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/3\" class=\"nounderline abstract_t\">Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev 1993; 6:89.</a></li><li class=\"breakAll\">Restrepo A, Tobon AM, Agudelo CA. Paracoccidioidomycosis. In: Diagnosis and Treatment of Human Mycoses, 1st edition, Hospenthal, DR, Rinaldi, MG (Eds), Humana Press, Totowa, NJ 2008. p.331.</li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/5\" class=\"nounderline abstract_t\">Pereira RM, Bucaretchi F, Barison Ede M, et al. Paracoccidioidomycosis in children: clinical presentation, follow-up and outcome. Rev Inst Med Trop Sao Paulo 2004; 46:127.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/6\" class=\"nounderline abstract_t\">Nogueira MG, Andrade GM, Tonelli E. Clinical evolution of paracoccidioidomycosis in 38 children and teenagers. Mycopathologia 2006; 161:73.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/7\" class=\"nounderline abstract_t\">de Camargo ZP. Serology of paracoccidioidomycosis. Mycopathologia 2008; 165:289.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/8\" class=\"nounderline abstract_t\">Yamaga LY, Benard G, Hironaka FH, et al. The role of gallium-67 scan in defining the extent of disease in an endemic deep mycosis, paracoccidioidomycosis: a predominantly multifocal disease. Eur J Nucl Med Mol Imaging 2003; 30:888.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/9\" class=\"nounderline abstract_t\">Morej&oacute;n KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study. Am J Trop Med Hyg 2009; 80:359.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis/abstract/10\" class=\"nounderline abstract_t\">Almeida FA, Neves FF, Mora DJ, et al. Paracoccidioidomycosis in Brazilian Patients With and Without Human Immunodeficiency Virus Infection. Am J Trop Med Hyg 2017; 96:368.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2438 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H11\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Signs and symptoms</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Laboratory abnormalities</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Clinical course</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">DIAGNOSTIC TESTS</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">EVALUATION</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">Approach to diagnosis</a></li></ul></li><li><a href=\"#H10\" id=\"outline-link-H10\">IMMUNOCOMPROMISED HOSTS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/2438|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/54429\" class=\"graphic graphic_picture\">- Acute subacute paracocci</a></li><li><a href=\"image.htm?imageKey=ID/52733\" class=\"graphic graphic_picture\">- Acute paracoccoci</a></li></ul></li><li><div id=\"ID/2438|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/65466\" class=\"graphic graphic_table\">- Acute paracocci findings</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-paracoccidioidomycosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of chronic paracoccidioidomycosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mycology-and-epidemiology-of-paracoccidioidomycosis\" class=\"medical medical_review\">Mycology and epidemiology of paracoccidioidomycosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-paracoccidioidomycosis\" class=\"medical medical_review\">Treatment of paracoccidioidomycosis</a></li></ul></div></div>","javascript":null}